Summary:
Trial is approximately 54 weeks of a single IV dose (monthly) which has demonstrated efficacy for the preventive treatment of Migraine Headache in patients with high frequency of migraine days.
Qualified Participants Must:
• Be between 18 and 55 years of age
•
Have had a diagnosis of Migraine Headache at age 35 or younger with a history of a Chronic Migraine greater than one year
•
Have 15-25 headache days/month with at least 8 of the headache days identified as Migraine days
•
Be willing to fill out a daily headache diary for a screening period of 28 days
•
If currently taking medications eg., Fiorinal, Fioricet or any other combination or opiate - must be taking these for at least 3 months
•
Be taking medications for at least 3 months if you are currently taking medications such as Fiorinal, Fioricet or any other combination or opiate
•
Not have Fibromyalgia, Chronic Low Back Pain or any Pain Syndrome that requires use of regular pain medication
•
Not have a history of chronic tension-type headache, cluster headache, new daily persistent headache, migraine with brainstem aura or sporadic and familial hemiplegic migraine
•
Not have treatments with Botox for migraine or any other medical/cosmetic response requiring injections in head, face, or neck within 6 months of screening for study
Qualified Participants May Receive:
Study medication at no charge, ongoing medical evaluation and follow up, and reimbursement for travel and inconvenience.